Remedium Bio is a gene therapy company focused on the development of treatments for large unmet clinical needs. To enable this, we developed a revolutionary gene therapy platform technology, which enables safe, effective, and durable delivery of therapeutic genes while allowing for simple post-treatment dose adjustment. The Prometheus™ adjustable gene therapy platform is able to safely and durably replace multi-injection subcutaneously administered biologics, with a single treatment, at a fraction of the cost, and without genetic integration. Our lead product is a disease-modifying treatment for Osteoarthritis that is based on the only clinically validated chondro-regenerative mechanism. Remedium’s pipeline includes gene therapy treatments in the fields of Weight Loss, Type 2 Diabetes, and Stroke.
| Website | http://www.remedium-bio.com |
| Employees | 19 (12 on RocketReach) |
| Founded | 2020 |
| Address | 1116 Great Plain Ave Suite 203, Needham, Massachusetts 02492, US |
| Phone | +1 978-467-5217 |
| Industry | Biotechnology |
| Keywords | Gene Therapy, Genetic Diseases, Rare Diseases, Gene Editing, Clinical Trials, Precision Medicine, Translational Research, Drug Delivery, Pharmaceutical Research, Therapeutics, Cell Therapy, Platform Technology, Research And Development, Medical Research, Biotechnology, Biopharma, Oncology, Immunotherapy, Life Sciences |
| Competitors | Novartis, Pfizer, GSK, AstraZeneca, Genentech, Amgen, Regeneron, Gilead Sciences, Moderna Therapeutics, Sangamo Therapeutics, Inc. +40 more (view full list) |
Looking for a particular Remedium Bio employee's phone or email?
Luppino is the President and CEO of Remedium Bio.
12 people are employed at Remedium Bio.
Remedium Bio is based in Needham, Massachusetts.